Mutual Of America Capital Management LLC Aptinyx Inc. Transaction History

Mutual Of America Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 12, 2019	SELL	$2.95 - $4.38 $192,487 - $285,795	-65,250 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$3.99 - $19.33 $4,720 - $22,867	1,183 Added 1.85%	65,250 $264,000
Q4 2018 Feb 12, 2019	BUY	$16.15 - $28.93 $414,651 - $742,777	25,675 Added 66.88%	64,067 $1.06 Million
Q3 2018 Nov 13, 2018	BUY	$20.21 - $31.85 $393,407 - $619,992	19,466 Added 102.85%	38,392 $1.11 Million
Q2 2018 Aug 09, 2018	BUY	$19.83 - $24.17 $375,302 - $457,441	18,926 New	18,926 $457,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Mutual Of America Capital Management LLC with notifications on news.